Summary
In 20 patients with long-standing essential hypertension, a comparison was made in a randomized cross-over study of the effect of once and twice daily prazosin administration on blood pressure levels. Concurrent medication (beta-blocker and/or saluretic once daily) remained constant throughout the study. Blood pressure measurements were carried out by a nurse using a Hawksley random zero sphygmomanometer, both in the clinic and at home, and using a Roche Kontron Arteriosonde SR-2 at home. Observations made in the morning and in the evening showed no significant difference in blood pressure between the once and twice daily treatments. Eight patients complained of dizziness and faintness half an hour after taking the once daily dose. However, they felt quite well on the twice daily regimen. The mean daily dose in these 8 patients was prazosin 8.4 mg, range 6–12 mg. No indication was found that the subjective adverse side effects were correlated with the serum prazosin level. The complaints noted may possibly be overcome by taking the once daily dose late in the evening, just before retiring. Better still, the development of a slow-release formulation for daily dosages of 6 mg and over is suggested.
Similar content being viewed by others
References
Okun R (1974) Dosage schedule routine for prazosin: two crossover trials comparing t. i. d. with q. i. d. administration. Proceedings Symposium on Prazosin, Geneva, 8 March 1974. Excerpta Medica, pp 82–91
Levia JL, Covarrubias E, Espinoza C (1978) Comparison of the antihypertensive effect of prazosin hydrochloride in two therapeutic schedules (Comparacion del efecto antihipertensivo del chlorhidrato de prazosin en dos esquemas terapeuticos). Investigacion Medica Internacional. 5 [1]: 33–36
Hunyor SN, Larkin H, Kenny P (1980) Continuous blood pressure measurement in ambulatory patients in the assessment of prazosin regimens. Med J Austr, Spec 2 [Suppl]: 15–16
Hunyor SN, Larkin H, Kenny P (1979) Comparative twenty four hour antihypertensive efficacy of once and twice daily prazosin therapy. In: Stott FD, Raftery EB, Goulding L (eds) ISAM 1979: Proc Third Internat Symp Ambulatory Monitoring. Academic Press, London pp 189–196
Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA (1983) Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 25: 339–384
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Westerman, R.F., Schouten, J.A. & Hengeveld, W.L. Prazosin once or twice daily?. Eur J Clin Pharmacol 28, 11–15 (1985). https://doi.org/10.1007/BF00635701
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00635701